The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Atorvastatin Liconsa 10 mg film-coated tablets

Laboratorios LICONSA, S.A.PA1239/028/001

Main Information

Trade NameAtorvastatin Liconsa 10 mg film-coated tablets
Active SubstancesAtorvastatin calcium trihydrate
Dosage FormFilm-coated tablet
Licence HolderLaboratorios LICONSA, S.A.
Licence NumberPA1239/028/001

Group Information

ATC CodeC10AA05 atorvastatin


License statusAuthorised
Licence Issued28/10/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0001-002-003
Interchangeable List DocumentPDF of Interchangeable List
« Back